跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要聚焦生存预测、分布迁移和校准,未明确研究因果效应或所列金融风险方向。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Hanxuan Ye
Hongzhe Li

删失生存数据的多重校准与普适适应性

研究问题
训练与目标人群存在协变量分布变化且目标结局未标注时,如何校准生存概率和限制平均生存时间,并兼顾不同亚群?
方法与思路
作者为删失生存数据设计黑箱后处理提升算法,使用伪观测实现多重校准,并以泛函 delta 方法等工具分析理论性质。
材料陈述的贡献
摘要称给出样本复杂度、收敛和校准保证,建立多重校准与普适适应性的联系,并与逆倾向加权进行理论和数值比较。
阅读关注点
应核对协变量偏移与删失机制条件、校准所覆盖的亚群集合,以及普适适应性和相对逆倾向加权优势采用的评价标准。
阅读边界
仅据所给 Crossref 摘要,不能推断任意分布变化下均有效,也不能确认普遍优于加权方法;公平性定义和效果幅度未说明。

原文摘要

Summary Traditional statistical and machine learning methods typically assume that the training and test data follow the same distribution. However, this assumption is frequently violated in real-world applications, where the training data in the source domain may underrepresent specific subpopulations in the test data of the target domain. This article addresses target-independent learning under covariate shift, focusing on multicalibration for survival probability and restricted mean survival time. A black-box post-processing boosting algorithm specifically designed for censored survival data is introduced. By leveraging pseudo-observations, our method produces a multicalibrated predictor that is competitive with inverse propensity score weighting in predicting the survival outcome in an unlabelled target domain, ensuring, not only overall accuracy, but also fairness across diverse subpopulations. Our theoretical analysis of pseudo-observations builds upon the functional delta method and the $ p $-variational norm. The algorithm’s sample complexity, convergence properties and multicalibration guarantees for post-processed predictors are provided. The results establish a fundamental connection between multicalibration and universal adaptability, demonstrating that our calibrated function is comparable to, or outperforms, the inverse propensity score weighting estimator. Extensive numerical simulations and a real-world case study on cardiovascular disease risk prediction using two large prospective cohort studies validate the effectiveness of our approach.

笔记与分组